Portuguese | English

Pressione Enter para iniciar a Busca.

Volume 115, Nº 2, August 2020


DOI: https://doi.org/10.36660/abc.20200424


Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) – 2020

Alexandre de Matos Soeiro

Tatiana de Carvalho Andreucci Torres Leal

Marcel de Paula Pereira

Eduardo Gomes Lima

Ana Cristina Baptista da Silva Figueiredo

João Luiz Fernandes Petriz

Dalton Betolim Precoma

Carlos Vicente Serrano Jr.

Figure 1 – Management suggestion and flowchart for assessing anticoagulant therapy in critically ill patients with COVID-19. RR: respiratory rate; SIC: sepsis-induced coagulopathy; INR: international normalized ratio; SOFA: sequential organ failure assessment; DIC: disseminated intravascular coagulation; ULN: upper limit of normal.